Wyeth announces fen-phen claims deal
(8/13/2004) - The Associated Press has reported that more than 40,000 former fen-phen users who claim the diet drugs caused minor heart valve damage would be compensated faster - but get significantly less money - under a proposed deal to speed review of less-serious cases in the protracted litigation.
According to AP, the agreement, between drugmaker Wyeth and lawyers representing more than 100,000 former users of its Pondimin and Redux pills, would set up a new $1.275 billion fund, Madison-based Wyeth told The Associated Press Wednesday. That fund would cover payments for about 40,170 people with non-life-threatening valve damage, the biggest group of claimants.
Click here for article